News


Jingxin Donates 10 Million Yuan in Cash and Medical Supplies to Aid Epidemic Areas


Recently, the outbreak of the novel coronavirus pneumonia has deeply touched the hearts of people across the nation.

The virus is ruthless, but Jingxin is full of compassion!

Countless medical staff have rushed to the front lines, sacrificing family reunions and disregarding their own safety! How could we let these heroes, who march against the flow, walk into danger alone?

To this end, Jingxin Group has decided to donate 5 million RMB in cash through the Zhejiang Red Cross Society. These funds will be used to purchase protective gear such as masks and protective suits for medical staff, provide care subsidies, and fully support epidemic prevention and treatment efforts.

Meanwhile, based on the "Four Antagonisms and Two Balances" treatment protocol for COVID-19 summarized by Academician Li Lanjuan, President of Shulan (Hangzhou) Hospital, maintaining micro-ecological balance and preventing secondary infections are proven and highly effective strategies for treating severe patients.

Accordingly, Jingxin Group has decided to donate medicines valued at 5 million RMB to the severely affected areas in Hubei. This includes the probiotic preparation—Jingchangle (Bacillus Licheniformis Capsules), used to regulate micro-ecological balance and reduce secondary infections caused by bacterial translocation; the anti-infective drug—Jingbituoxin (Levofloxacin Tablets); as well as other related medical supplies such as Kangfuxin Liquid and Azithromycin Tablets, which are being urgently delivered to the clinical front lines.

Actively practicing its mission of "Carefully Guarding Health," Jingxin Group is bravely shouldering its social responsibility as a pharmaceutical enterprise by expediting the production of medicines urgently needed during the epidemic.

Donating ten million to aid the epidemic-stricken areas, Jingxin stands with you